| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 03/09/2005 | EP1512014A2 Methods for the identification of all-antigens and their use for cancer therapy and transplantation |
| 03/09/2005 | EP1511772A2 Method for obtaining anti-idiotype antibodies |
| 03/09/2005 | EP1511765A1 Par-2-activating peptide derivative and pharmaceutical composition using the same |
| 03/09/2005 | EP1511764A2 PEPTIDES AND PEPTIDOMIMETICS USEFUL FOR INHIBITING THE ACTIVITY OF PROSTAGLANDIN F sb 2a /sb RECEPTOR |
| 03/09/2005 | EP1511763A2 Intracellular delivery of biological effectors |
| 03/09/2005 | EP1511761A1 Process for production of cyclic peptides |
| 03/09/2005 | EP1511760A2 Carboxy protection strategies for acidic c-terminal amino acids in chemical ligation of oligopeptides |
| 03/09/2005 | EP1511519A1 Modified byrodin 1 with reduced immunogenicity |
| 03/09/2005 | EP0932613B1 Blocking expression of virulence factors in s. aureus |
| 03/09/2005 | EP0845943B1 Novel peptides derived from human heat shock protein 60 for treatment of diabetes, compositions, methods and kits |
| 03/09/2005 | EP0779076B1 Peptide, a method of obtaining it and a pharmaceutical compound based on it |
| 03/09/2005 | CN1592753A Methods for preparing purified daptomycin |
| 03/09/2005 | CN1592752A Inhibitors of the E2F-1/cyclin interaction for cancer therapy |
| 03/09/2005 | CN1592633A T-cell epitodes in carboxypeptidase G2 |
| 03/09/2005 | CN1590403A Hexapeptide and its application |
| 03/08/2005 | US6865492 Algorithmic design of peptides for binding and/or modulation of the functions of receptors and/or other proteins |
| 03/08/2005 | US6864355 Inhibition of NF-κB activation by blockade of IKKβ-NEMO interactions at the NEMO binding domain |
| 03/08/2005 | US6864239 Methods and compounds for prevention and treatment of elevated intraocular pressure and related conditions |
| 03/08/2005 | US6864234 Somatostatin agonists |
| 03/08/2005 | US6864233 Fungicidal echinocandin derivatives and their preparation |
| 03/03/2005 | WO2005019457A2 NON-MAMMALIAN GnRH ANALOGS AND USES THEREOF IN REGULATION OF FERTILITY AND PREGNANCY |
| 03/03/2005 | WO2005019448A2 NON-MAMMALIAN GnRH ANALOGS AND USES THEREOF IN REGULATION OF FERTILITY AND PREGNANCY |
| 03/03/2005 | WO2005019421A2 Crosslinking within coordination complexes |
| 03/03/2005 | WO2005019409A2 Combinatorial protein library screening by periplasmic expression |
| 03/03/2005 | WO2005019247A2 Cyclic peptide and imaging compound compositions and uses for targeted imaging and therapy |
| 03/03/2005 | WO2005019245A1 Heptadepsin |
| 03/03/2005 | WO2005019244A1 Peptides which can bind to transforming growth factor beta 1 (tgf-beta1) |
| 03/03/2005 | WO2005019241A2 Cationic antimicrobial peptides and compositions thereof |
| 03/03/2005 | WO2005018657A2 NON-MAMMALIAN GnRH ANALOGS AND USES THEREOF IN REGULATION OF FERTILITY AND PREGNANCY |
| 03/03/2005 | WO2005018575A2 Estrogen receptor modulators and uses thereof |
| 03/03/2005 | WO2004073640A3 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy |
| 03/03/2005 | WO2004063213A3 Peptides which target tumor and endothelial cells, compositions and uses thereof |
| 03/03/2005 | US20050049234 Cyclic lactams comprising three amino acids and a tether chain to control the overall shape of the macromolecule; beta-turn mimetics to explore conformationally restricted structures; proteolytic enzyme resistance (nonhydrolyzing); cell penetration; anticoagulants; anticarcinogenic agents |
| 03/03/2005 | US20050049201 Detection and removal of lead using lead-binding proteins |
| 03/03/2005 | US20050049197 Induction of immune response against desired determinants |
| 03/03/2005 | US20050049186 Peptides mimicking the biological activity of steroid hormones and their uses |
| 03/03/2005 | US20050048629 theTat peptide is self cell-penetrating, is of HIV Type-1 and is bound to N-terminal amino acid residue of human parathyroid hormone-derived peptide; high stability and superior skin absorption; superior lipolysis effects and improved durability |
| 03/03/2005 | US20050048584 Method for detecting alzheimer's disease and differentiating alzheimer's disease from other demential diseases associated peptides and use thereof |
| 03/03/2005 | US20050048579 Using three dimensional structure of cellular adhesion molecule to drug design non-peptide modulator of cellular adhesion molecule activity; designing drugs for treatment of cell proliferative and autoimmune diseases |
| 03/03/2005 | US20050048068 Major histocompatibility complex epitopes; immunotherapy ; induce immunology response |
| 03/03/2005 | US20050048066 Identification of potential immunodominant acetylcholine receptor alpha subunit |
| 03/03/2005 | US20050048063 Collagen-binding molecules that selectively home to tumor vasculature and methods of using same |
| 03/03/2005 | DE10335584A1 Verfahren zur Herstellung zyklischer Moleküle A process for preparing cyclic molecules |
| 03/03/2005 | CA2536946A1 Estrogen receptor modulators and uses thereof |
| 03/03/2005 | CA2535807A1 Peptides with the capacity to bind to transforming growth factor .beta.1 (tgf-.beta.1) |
| 03/03/2005 | CA2535513A1 Crosslinking within coordination complexes |
| 03/02/2005 | EP1510524A2 Compounds and peptides that bind to the erythropoietin receptor |
| 03/02/2005 | EP1509542A1 Methods for measuring kinase activity and phosphatase activity |
| 03/02/2005 | EP1509390A2 Carbon nanotube binding peptides |
| 03/02/2005 | EP1509240A2 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 03/02/2005 | EP0979244B1 Novel cyclosporin derivatives, preparation and pharmaceutical compositions containing same |
| 03/02/2005 | EP0846164B1 Method for assaying in vitro the proteolytic activity of polypeptides having hcv ns3 protease activity and peptide substrates to be used in this method. |
| 03/02/2005 | CN1589279A Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 03/02/2005 | CN1589257A N-methyl-homocysteines and their use as well as process for their production |
| 03/02/2005 | CN1589151A Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
| 03/02/2005 | CN1191273C Long lasting insulinotropic peptides |
| 03/02/2005 | CN1191272C Conjugates of lipophilic moieties and fragments of vasoactive intestinal peptide (VIP) |
| 03/02/2005 | CN1191269C Pseudomycin natural product |
| 03/01/2005 | US6861408 Therapeutic anti-melanoma compounds |
| 03/01/2005 | US6861406 Use of peptides or small molecules in treatment of disease, in high-throughput screening, in use of metal-binding peptides derived from sequences present in CD74-homology domain of insulin-like growth factor |
| 03/01/2005 | US6861057 Immunogenic β-amyloid peptide |
| 03/01/2005 | CA2114631C N-acetylglucosaminyltransferase v coding sequences |
| 02/24/2005 | WO2005016971A1 Organic material-immobiling structure and method for production of the same, and peptide and dna therefor |
| 02/24/2005 | WO2005016957A1 REAGENT FOR AMPLIFYING AMYLOID FIBROSIS OF AMYLOID β-PROTEIN |
| 02/24/2005 | WO2005016283A2 Peptides for enhanced cell attachment and growth |
| 02/24/2005 | WO2005016280A2 Orally administered small peptides synergize statin activity |
| 02/24/2005 | WO2005016260A2 Prodrugs for the oral and parenteral delivery of amine-containing drugs, amino acids, and peptides |
| 02/24/2005 | WO2005016248A2 A novel antiproliferative factor and methods of use |
| 02/24/2005 | WO2005016244A2 Methods and compositions for the treatment of gastrointestinal disorders |
| 02/24/2005 | WO2005016232A2 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins |
| 02/24/2005 | WO2004104031A3 Modified antiviral peptides with increased activity and cell membrane affinity |
| 02/24/2005 | WO2004056865A3 Method of modulation of interaction between receptor and ligand |
| 02/24/2005 | WO2004052923A3 Process for the preparation of bicyclic hexa-peptide nepadutant |
| 02/24/2005 | WO2004024088A3 Design of chemokine analogs for the treatment of human diseases |
| 02/24/2005 | WO2003018758A3 Reagents and methods for smooth muscle therapies |
| 02/24/2005 | US20050043538 Peptide beta-strand mimics based on 1,2-dihydro-3(6H)-pyridinone |
| 02/24/2005 | US20050043245 Chicken II GnRH decapeptide analog having sequence p-Glu-His-Trp-Ser-His-Xaa1-Trp-Tyr-Pro-Xaa2, capable of binding to GnRH receptors within immune system and active in presence of post-proline peptidase or endopeptidase, comprising D-amino acid substitution at position 6 and amide at 10; immune disorders |
| 02/24/2005 | US20050043226 having a building unit containing one nitrogen atom of the peptide backbone connected to a bridging group comprising an amide, thioether, thioester, or disulfide; used to treat cancers, diabetes, diabetic-associated complications, endocrine disorders, gastrointestinal disorders, and pancreatitis |
| 02/24/2005 | US20050043213 Inhibiting secondary amide peptide bond cis/trans isomerases (APIases); screening for enzyme inhibitors; anticarcinogenic, antiproliferative agents; hyperplasia |
| 02/24/2005 | US20050042623 Microarray comprising an immobilized addressed collection of polypeptide-tagged molecules for use as tool in evaluating and monitoring intracellular and extracellular biological activities |
| 02/24/2005 | US20050042602 Monitoring immunologic, Hematologic and inflammatory diseases |
| 02/24/2005 | DE10334777A1 New antiproliferative peptide, useful for treating tumors, atherosclerosis or psoriasis, comprises a segment that mediates binding to extracellular matrix and a nuclear localization sequence |
| 02/24/2005 | CA2534676A1 Orally administered small peptides synergize statin activity |
| 02/24/2005 | CA2530803A1 A novel antiproliferative factor and methods of use |
| 02/24/2005 | CA2529307A1 Methods and compositions for the treatment of gastrointestinal disorders |
| 02/24/2005 | CA2526339A1 Polyvalent immunogen |
| 02/23/2005 | EP1508047A2 Method for identifying immunoreactive peptides |
| 02/23/2005 | EP1507795A1 Tumour-associated peptides that bond to mhc molecules |
| 02/23/2005 | EP1507794A2 Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments |
| 02/23/2005 | EP1507549A2 Drug therapy for celiac sprue |
| 02/23/2005 | EP1507508A1 Composition containing a peptide and a pigment and the use thereof in darkening the skin |
| 02/23/2005 | EP1311280A4 Cell internalized peptide-drug conjugates |
| 02/23/2005 | EP0876337B1 New lh-rh antagonists with improved effectiveness |
| 02/23/2005 | EP0783524B1 Peptides and pharmaceutical compositions comprising them |
| 02/23/2005 | CN1585778A Modified anti-TNF alpha antibody |
| 02/23/2005 | CN1583785A Neutral and variable sites of cytomembrane protein M2 of influenza virus and their use |
| 02/22/2005 | US6858585 Cyclic depsipeptides and drugs containing the same as the active ingredient |
| 02/22/2005 | US6858581 Peptides which are modified with at least one hydrocarbyl group and which possess antimicrobial acitivity |
| 02/22/2005 | US6858576 Methods for regulating gastrointestinal motility |
| 02/22/2005 | US6858438 Peptides immunoreactive with autoantibodies from patients with rheumatoid arthritis |